Cellex supports biopharma and academia with a full portfolio of services around cell and gene therapy for research, clinical and commercial use worldwide. 

Our company has experience in development of cGMP processes, GMP manufacturing of autologous and allogeneic cell therapy products using vectors and LNPs, quality control testing and release. 

In our state-of-the-art GMP facility cellular subsets can be separated and frozen but also genetically modified and analyzed. All processes are adapted to the customers’ needs, based on profound experience with EU and FDA regulations. 

Cellex also stands for a successful tech transfer of processes from US to Europe. 

Our apheresis center is specialized in collections of different starting materials from healthy and diseased donors. Cellex runs its own highly diverse donor pool and offers fresh leukopaks, mobilized cells, bone marrow or whole blood products customized for R&D, clinical or commercial purposes. 

IT and transport solutions complete the Cellex portfolio. 

WhiteLab Genomics is a fast-growing in-silico deeptech start-up that is reinventing the research and early development of new genomic medicines. We are developing and using Artificial Intelligence to accelerate the discovery, design and bioproduction of these innovative biotherapies. We are collaborating with top notch academics, biotech companies, and pharmaceutical firms in Europe and North America, to tackle significant challenges in developing innovative genomic medicines notably for rare diseases, neurodegenerative diseases, oncology, ophthalmology. 

Scinus Cell Expansion provides technologies and process development to enable and improve cell therapy and regenerative medicine. Our main product is the SCINUS bioreactor NG, which is a closed bioreactor system for the controlled cultivation of cells, supporting R&D as well as GMP processes. Combined with either the single-use Adherent or Suspension Bag it provides a scalable system for large-fold expansion. The temperature-controlled hardware enclosure houses the Single-use Bags on a unique, volume-expandable, rocking platform that provides an optimally homogenized culture environment with minimal shear stresses. Two different single use bioreactor bag can be used to cultivate adherent cells (e.g. human mesenchymal stromal cells), as well as suspension cells (e.g. T-cells, NK cells) to clinically relevant numbers. Both bags can be used with the same Scinus Cell Expansion system configuration. For an illustrative animation, please check our website (www.scinus.com). 

MyCellHub is a one-stop-shop software platform for process development, data recording and data analytics of GMP operations. From batch recording to cleanroom cleaning, we eliminate all paperwork in the cleanroom to reduce errors, streamline quality compliance and provide data-driven optimization for GMP operations. 
 
MyCellHub isn’t just about swapping out paper for pixels. It’s about reimagining the biomanufacturing landscape with impulses of innovation, agility, and precision. It’s about connecting the dots of data, decoding the patterns, and using these insights to drive decisions faster. It’s about making life-saving biotherapeutics, like gene and cell therapies, more efficacious, less expensive, and delivered to the patients as fast as possible. 
 
We’re a team of 18 people. Half of the team has a background in biomanufacturing and life sciences, while the other half are software developers. MyCellHub’s HQ is located in Belgium but we recently opened an office in the US.

3P innovation is a dynamic and successful engineering and automation company, with a strong reputation for helping multi-national customers to develop, produce and commercialise new products quickly and cost effectively. Their ‘Pharma equipment’ brand covers their unique equipment portfolio, designed to support customers through the different phases of their product’s lifecycle. Whilst their ‘Custom automation’ brand covers their traditional area of business, in which they work collaboratively with customers to support product and process innovation and development.

They are active in the cell and gene sector, parenterals, reconstitution devices, inhalers and sustained release drug products. Their lab-scale and benchtop systems are ideally suited to the small batch high sensitivity of ATMP’s and cell & gene therapies.

Experience 3P innovation’s technologies in hyper-realistic 3D: https://www.3pinnovation.com/media-events/virtual-showroom